Datta Priya, Rattan Divya, Sharma Devyani, Sharma Navneet, Kalra Naveen, Duseja Ajay, Angrup Archana, Sehgal Rakesh
Department of Medical Parasitology, PGIMER, Chandigarh, India.
Department of Internal Medicine, PGIMER, Chandigarh, India.
Infect Dis (Lond). 2024 Apr;56(4):259-267. doi: 10.1080/23744235.2023.2294119. Epub 2023 Dec 19.
Amoebic liver abscess (ALA) is commonly seen in tropical countries and diagnosis of ALA relies mainly on non-specific serological and imaging techniques as well as PCR from pus.
This study evaluated the potential of using cell free DNA (cfDNA) from serum and urine for diagnosing ALA.
We prospectively evaluated quantitative PCR (qPCR) for detection of cf DNA in serum and urine sample in all liver abscess patients. The samples were collected from patients reporting to emergency ward of Postgraduate Institute of Medical Education and Research, Chandigarh, India with symptoms suggestive of liver abscess. Real time PCR was done to detect cf DNA in serum and urine by targeting 99-bp unit of of and conventional PCR for pus.
A total 113 samples (serum and urine) and 100 pus samples were analysed. A total of 62 ALA patients were confirmed; with maximum 57 patients detected by qPCR for cfDNA in the serum, 55 patients by PCR on pus aspirate and 50 ALA patients by qPCR for cfDNA in urine sample. Therefore, the sensitivity of qPCR for detection of cf DNA in serum was 91.94% and for urine was 80.65%.
A total of 11.2% of ALA patients were diagnosed only through detection of cf DNA in their and urine. Detection of cfDNA from serum, urine of ALA has a potential role in future especially for developing countries as it is a rapid, sensitive and patient friendly diagnostic approach.
阿米巴肝脓肿(ALA)在热带国家较为常见,ALA的诊断主要依靠非特异性血清学和影像学技术以及脓液的聚合酶链反应(PCR)。
本研究评估了利用血清和尿液中的游离DNA(cfDNA)诊断ALA的潜力。
我们前瞻性地评估了定量PCR(qPCR)在检测所有肝脓肿患者血清和尿液样本中cfDNA的情况。样本取自印度昌迪加尔医学教育与研究研究生院急诊室报告有肝脓肿症状的患者。通过靶向 的99碱基对单位进行实时PCR检测血清和尿液中的cfDNA,对脓液进行常规PCR检测。
共分析了113份样本(血清和尿液)和100份脓液样本。共确诊62例ALA患者;血清中cfDNA的qPCR检测出最多57例患者,脓液抽吸物的PCR检测出55例患者,尿液样本中cfDNA的qPCR检测出50例ALA患者。因此,血清中cfDNA检测的qPCR敏感性为91.94%,尿液为80.65%。
共有11.2%的ALA患者仅通过检测其血清和尿液中的cfDNA得以确诊。从ALA患者的血清、尿液中检测cfDNA在未来具有潜在作用,尤其是对发展中国家而言,因为这是一种快速、敏感且对患者友好的诊断方法。